Siglec-3 antibodies (Palleon Pharma)

N/A

Report date: 2025/01/26 16:12:40

Base Information

Drug NameSiglec-3 antibodies (Palleon Pharma)
Drug Alias NameCD33 checkpoint inhibitors (Palleon Pharma)CD33 antibodies (Palleon Pharma)siglec-3 checkpoint inhibitor (Palleon Pharma)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionMyeloid cell surface antigen CD33 inhibitors
TargetsMyeloid cell surface antigen CD33
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPalleon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPalleon Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A